Pages that link to "Q34562555"

The following pages link to Systemic distribution of somatostatin receptor subtypes in human: an immunohistochemical study (Q34562555):

Displaying 44 items.

• The role of the neuropeptide Y (NPY) family in the pathophysiology of inflammatory bowel disease (IBD) (Q26782555) (← links)
• PI3K-AKT-mTOR-signaling and beyond: the complex network in gastroenteropancreatic neuroendocrine neoplasms (Q26862544) (← links)
• Imaging of gastroenteropancreatic neuroendocrine tumors (Q28238305) (← links)
• Expression of somatostatin and somatostatin receptor subtypes 1-5 in human normal and diseased kidney (Q30487782) (← links)
• Does somatostatin have a role in the regulation of cortisol secretion in primary pigmented nodular adrenocortical disease (ppnad)? a clinical and in vitro investigation (Q33569023) (← links)
• Molecular imaging with ⁶⁸Ga-SSTR PET/CT and correlation to immunohistochemistry of somatostatin receptors in neuroendocrine tumours. (Q33917064) (← links)
• Comparing of IRS and Her2 as immunohistochemical scoring schemes in gastroenteropancreatic neuroendocrine tumors (Q34257556) (← links)
• Association between somatostatin receptor 5 gene polymorphisms and pancreatic cancer risk and survival (Q35103474) (← links)
• Effects of the somatostatin receptor subtype 4 selective agonist J-2156 on sensory neuropeptide release and inflammatory reactions in rodents (Q35995735) (← links)
• Somatostatin receptor staining in FFPE sections using a ligand derivative dye as an alternative to immunostaining (Q36275836) (← links)
• Expression of somatostatin receptors (SSTR1-SSTR5) in meningiomas and its clinicopathological significance (Q36375359) (← links)
• Pasireotide is more effective than octreotide in reducing hepatorenal cystogenesis in rodents with polycystic kidney and liver diseases. (Q36739229) (← links)
• Effects of AP‑1 and NF‑κB inhibitors on colonic endocrine cells in rats with TNBS‑induced colitis (Q37083066) (← links)
• Growth hormone-independent suppression of growth hormone-dependent female isoforms of cytochrome P450 by the somatostatin analog octreotide (Q37138295) (← links)
• Impaired defense mechanism against inflammation, hyperalgesia, and airway hyperreactivity in somatostatin 4 receptor gene-deleted mice. (Q37293161) (← links)
• Effects of therapy with [177Lu-DOTA 0,Tyr 3]octreotate on endocrine function (Q37392534) (← links)
• Diffuse endocrine system, neuroendocrine tumors and immunity: what's new? (Q37976162) (← links)
• Monoclonal antibodies against the human somatostatin receptor subtypes 1-5: development and immunohistochemical application in neuroendocrine tumors (Q38406569) (← links)
• Gastrointestinal neuroendocrine peptides/amines in inflammatory bowel disease (Q38622923) (← links)
• Novel gold nanoparticles coated with somatostatin as a potential delivery system for targeting somatostatin receptors. (Q38782137) (← links)
• (68)Ga-DOTATATE PET in juvenile angiofibroma (Q38895856) (← links)
• Treatment of transplanted tumor of lung adenocarcinoma A549 transfected by human somatostatin receptor subtype 2 (hsstr2) gene with 188Re-RC-160 (Q39635115) (← links)
• Exploring new frontiers in molecular imaging: Emergence of68Ga PET/CT (Q39805119) (← links)
• Somatostatin and opioid receptors do not regulate proliferation or apoptosis of the human multiple myeloma U266 cells (Q39842258) (← links)
• Comparison of immunoreactive score, HER2/neu score and H score for the immunohistochemical evaluation of somatostatin receptors in bronchopulmonary neuroendocrine neoplasms (Q41496806) (← links)
• Tumoral prostate shows different expression pattern of somatostatin receptor 2 (SSTR2) and phosphotyrosine phosphatase SHP-1 (PTPN6) according to tumor progression. (Q41815304) (← links)
• Expression of the somatostatin receptor subtype 4 in intact and inflamed pulmonary tissues (Q41826791) (← links)
• Peptide receptor radionuclide therapy using radiolabeled somatostatin analogs: focus on future developments (Q42345704) (← links)
• Somatostatin and somatostatin receptors: from basic concepts to clinical applications (Q43028510) (← links)
• Somatostatin receptor type 2 antagonism improves glucagon counterregulation in biobreeding diabetic rats (Q43083184) (← links)
• Octreotide therapy for the management of refractory chylous ascites after a staging operation for endometrial adenocarcinoma (Q44820089) (← links)
• Immunohistochemical detection of somatostatin receptor (SSTR) subtypes 2A and 5 in pituitary adenoma from acromegalic patients: good correlation with preoperative response to octreotide (Q46911427) (← links)
• Immunohistochemical evaluation of molecular radiotherapy target expression in neuroblastoma tissue (Q47771714) (← links)
• 99mTc-HYNIC-TOC increased uptake can mimic malignancy in the pancreas uncinate process at somatostatin receptor SPECT/CT. (Q48106376) (← links)
• Expression and characterization of bifunctional fusion proteins possessing antitumor and thrombolytic function for targeting therapy. (Q53628511) (← links)
• Clinicopathological characterization of TSH-producing adenomas: special reference to TSH-immunoreactive but clinically non-functioning adenomas. (Q54464204) (← links)
• Somatostatin Decorated Quantum Dots for Targeting of Somatostatin Receptors. (Q54945660) (← links)
• International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature (Q57144951) (← links)
• Tuberculosis in children presenting with chylothorax - Report of two cases and review of the literature (Q64106587) (← links)
• Somatostatin and dopamine receptor profile of gastroenteropancreatic neuroendocrine tumors: an immunohistochemical study (Q83348493) (← links)
• Immunohistochemical evaluation of somatostatin receptor subtypes in surgical pathology specimens of neuroendocrine tumors (Q84974647) (← links)
• Anti-inflammatory Effect of Somatostatin Analogue Octreotide on Rheumatoid Arthritis Synoviocytes (Q88873938) (← links)
• Somatostatin receptor expression in parathyroid neoplasms (Q92125116) (← links)
• Somatostatin receptors as a new active targeting sites for nanoparticles (Q92986968) (← links)